NCT02451956 2019-12-30Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line ChemotherapySamsung Medical CenterPhase 2 Completed21 enrolled